Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Generation Bio (GBIO) Depreciation & Amortization (CF) (2021 - 2025)

Historic Depreciation & Amortization (CF) for Generation Bio (GBIO) over the last 5 years, with Q3 2025 value amounting to $1.4 million.

  • Generation Bio's Depreciation & Amortization (CF) rose 1666.67% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year decrease of 593.35%. This contributed to the annual value of $4.9 million for FY2024, which is 696.23% down from last year.
  • Latest data reveals that Generation Bio reported Depreciation & Amortization (CF) of $1.4 million as of Q3 2025, which was up 1666.67% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Generation Bio's Depreciation & Amortization (CF) ranged from a high of $1.4 million in Q3 2022 and a low of $1.1 million during Q1 2021
  • Its 5-year average for Depreciation & Amortization (CF) is $1.2 million, with a median of $1.2 million in 2021.
  • Per our database at Business Quant, Generation Bio's Depreciation & Amortization (CF) soared by 1890.46% in 2022 and then tumbled by 1696.04% in 2024.
  • Quarter analysis of 5 years shows Generation Bio's Depreciation & Amortization (CF) stood at $1.1 million in 2021, then rose by 18.9% to $1.3 million in 2022, then rose by 1.19% to $1.4 million in 2023, then fell by 16.96% to $1.1 million in 2024, then grew by 23.78% to $1.4 million in 2025.
  • Its last three reported values are $1.4 million in Q3 2025, $1.2 million for Q2 2025, and $1.1 million during Q1 2025.